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Abstract
Background: The increasing regulatory requirements to which biological agents are subjected will have a great
impact in the field of industrial protein expression and production. There is an expectation that in a near future,
there may be “zero tolerance” towards antibiotic-based selection and production systems. Besides the antibiotic
itself, the antibiotic resistance gene is an important consideration. The complete absence of antibiotic-resistance
gene being the only way to ensure that there is no propagation in the environment or transfer of resistance to
pathogenic strains.
Results: In a first step, we have designed a series of vectors, containing a stabilization element allowing a
complete elimination of antibiotics during fermentation. Vectors were further improved in order to include
alternative selection means such as the well known poison/antidote stabilization system. Eventually we propose an
elegant positive pressure of selection ensuring the elimination of the antibiotic-resistance gene through
homologous recombination. In addition, we have shown that the presence of an antibiotic resistance gene can
indirectly reduce the amount of expressed protein, since even in absence of selection pressure the gene would be
transcribed and account for an additional stress for the host during the fermentation process.
Conclusions: We propose a general strategy combining plasmid stabilization and antibiotic-free selection. The
proposed host/vector system, completely devoid of antibiotic resistance gene at the end of construction, has the
additional advantage of improving recombinant protein expression and/or plasmid recovery.
Background
Antibiotics are commonly used during bacterial
fermentation, and the vast majority of expression vectors
contain antibiotic resistance genes as selection markers.
The degree of acceptance of these markers is both anti-
biotic and context dependent: Kanamycin and, to a les-
ser extent, Tetracycline, are still acceptable to the health
authorities. In contrast the use of b-lactams, often asso-
ciated with allergic responses, is strictly prohibited.
Requirement can also be variable according to the
nature of the therapeutic product, the presence of an
antibiotic resistance gene, tolerated on a vector
expressing a recombinant biopharmaceutical, will be
totally undesirable on a gene therapy plasmid.
Different strategies are currently used and are
described below.
Post-segregational killing
Post-segregational killing is a mechanism by which plas-
mids are stably maintained by expressing a gene product
that would be toxic to cells becoming plasmid-free upon
division.
The most representative example of post-segregational
killing of plasmid-free cells is the Hok/Sok system
described for the first time in 1986. The translation of
the Hok (host killing) messenger, encoding a toxin lethal
to the bacteria, is completely blocked by the anti-
messenger Sok (suppression of killing). In the absence of
plasmid, Sok, which is less stable than Hok,i sl o s tf i r s t ,
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sion of the toxin lethal to the cell [1].
Other examples of the mechanism known as post-
segregational killing have been reported such as
plasmids carrying type II restriction modification (RM)
gene complexes inhibiting the propagation of a cell
population following chromosome breakage [2].
Essential gene complementation
￿ The example of dapD
The most common way to achieve selection in the
absence of antibiotics is via complementation of an
essential gene making use of an expression vector in a
strain with a defect or inhibited expression of the same
essential gene. The dapD gene, which has a role in the
Lysine biosynthetic pathway as well as cell wall assem-
bly, has been selected as a preferred candidate by several
authors, knowing that mutations in the dap pathway are
lethal [3]. The limitations, in that case, are the intrinsic
difficulty in construction of a dapD - mutant strain and
dependence towards defined culture media composition.
￿ dapD and repressor titration
A more elaborated strategy still based on dapD was
described: the so-called “operator repressor titration for
antibiotic-free plasmid maintenance”,p r o p o s e db y
Cobra Therapeutics, is a model in which the plasmid
loss induces the downregulation of the essential dapD
gene, and thus bacterial death [4].
￿ Translation initiation factor infA
As alternatives to dapD, other essential genes have been
targeted for the same purpose, particularly infA coding
for a translation initiation factor [5]. The authors show
that the system is tightly regulated and that no cross-
feeding effect is observed since initiation factors released
into the media from lyzed cells are not absorbed by
plasmid-free cells.
￿ Amino-acid auxotrophy complementation
A proline-auxotrophic K12 strain obtained through
chromosomal proBA gene deletion is described [6] for
the expression of antibody Fab fragment. In that parti-
cular case the plasmid-mediated complementation is
used as a second selection mechanism to completely
abolish plasmid loss during fermentation.
According to the same principle an E. coli M15-
derivated glycine-auxotrophic strain has been
constructed and shown to produce comparable amounts
of recombinant protein as a conventional system [7].
￿ The murA gene and RNA/RNA interaction
The principle of down regulating an essential gene upon
plasmid loss has been exploited in a very original way
for the design of new vectors for gene therapy [8,9]. The
expression of the essential gene murA encoding an
enzyme essential for the biosynthesis of cell wall is
under control of the Tet repressor, TetR expression is
inhibited by an RNA-RNA antisense interaction with
RNAI derived from plasmid origin of replication ColE1.
The major advantage of this system is that no additional
sequence is required on the plasmid.
￿ RNA-OUT based antibiotic-free selection system
In a recent paper [10], a RNA based selectable marker,
not restricted to ColE1 containing vectors is described.
Briefly, a counter-selectable marker (sacB) levansucrase
from Bacillus subtilis, under control of the RNA-IN pro-
moter is integrated into the bacterial chromosome
induces cell death in presence of sucrose.
Plasmid maintenance is ensured by the presence of
the plasmid-borne regulator RNA-OUT anti-messenger
acting as a down regulator of the expression of
levansucrase.
Plasmid selection using an endogenous essential gene
marker
A potential drawback of essential gene complementation
is the requirement of engineering mutant host strains
and using specifically defined media. The fabl-triclosan
model system recently proposed is based on the over-
expression of a host essential gene in presence of a che-
mical inhibitor of its product [11].
￿ Mutual dependence: the pCOR system
Other systems such as pCOR, based on the complemen-
tation of an amber mutation, and conditional origin of
replication have also been established. The original fea-
ture of the model is that an additional degree of refine-
ment was introduced, since the dependence created
between the host and the vector has become bilateral.
Nevertheless, the requirement for a minimal medium
for culture means these systems are more likely to be
used for DNA production rather than recombinant pro-
tein over expression [12].
Poison/Antidote selection
The original “Separate-component-stabilization system
for protein and DNA production without the use of
antibiotics” has recently been proposed by Szpirer et al
[13]. The selection is based on the following elements:
-G e n eccdB (the poison), inserted into the bacterial gen-
ome of the E. coli strain BL21l (DE3) and encoding a
stable protein (100 aa), binding gyrase, an essential ele-
ment for cell division. Upon binding gyrase, the ccdB gene
product impairs DNA replication and induces cell death.
- Gene ccdA (the antidote), plasmid-born, encodes an
instable protein (90 aa) under control of the mob pro-
moter, acting as a natural inhibitor of ccdB.
It has been shown that after 20 generations on a non
selective medium 100% of the bacteria still contain the
plasmid. Two hours after induction, the plasmid is still
present into all bacteria, which is not the case with a
standard pET/BL21lDE3 system.
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tems or more generally antibiotic-free systems have the
common drawback of being strain dependant, since
genetic knockout or modification of an essential gene is
not easily transferable from one strain to another and
has to be done independently for each strain. Strain
modification by chromosomal mutagenesis is still a
tedious approach, notwithstanding the existence of tech-
nologies making use of counter-selectable vectors or
PCR amplified fragments [14-16].
Plasmid stabilisation
A second aspect to be considered during the expression
of a recombinant biopharmaceutical is the plasmid sta-
bilisation that can be achieved by insertion of a genetic
element such as the cer locus, which allows stable
inheritance of ColE1 and related plasmids by preventing
the runaway accumulation of multimers known as
“dimer catastrophe” [17,18]. Multimer resolution is
achieved through action of the XerCD site-specific
recombinase at the cer site. Cloning of the cer locus into
various expression vectors has been extensively docu-
mented and the proof of principle largely established in
high-cell density cultures [19].
Here, we report a new strategy to overcome the need
for antibiotics in the production process, including
increasing plasmid stability and maintenance during fer-
mentation as well as the use of alternative, “antibiotic-
free” selection markers.
Results and Discussion
First step: Plasmid stabilisation
Plasmid stabilisation and increased maintenance during
a fermentation process can be considered as a first step
towards antibiotic starvation. Genetic elements allowing
plasmid maintenance during cell division and limiting
the probability of plasmid loss over generations should
be considered.
In a first series of experiments the stabilisation effect
of the cer locus was demonstrated during the expression
of different recombinant antigens from Helicobacter
pylori, at laboratory scale in shake flasks.
Two vectors, based on pET28 backbone, expressing
t h eA l p Ao rU r e a s ea n t i g e n sf r o mHelicobacter pylori
have been modified in order to include a DNA fragment
containing the cer locus in both orientations as com-
pared to the expression cassette. From a technical point
of view, the construct was done by ligation between two
PCR fragments containing respectively the cer fragment
and the entire pET28 plasmid devoid of the F1 origin.
The assembly was made possible by the complementar-
ity of two newly created unique restriction site brought
by the PCR primers used during the amplification steps.
The readout of the stability testing experiment was a
simple counting, after plating on selective medium, of
bacterial colonies still containing the plasmid at different
times of culture in absence of antibiotic selection.
As shown in tables 1 and 2, the plasmid maintenance
is dramatically increased due to the presence of the cer
fragment, whatever the antigen or the orientation of the
cer fragment considered. One should note that the nat-
ure of antigen itself has some influence on the mainte-
nance of the plasmid. In the case of Urease, the stability
decrease is more important, for both vectors, and once
again more marked for the vector devoid of cer frag-
ment as compared to the vector containing cer,w h a t -
ever the orientation considered. Dramatic differences
are already observed at time points between 2 and 6
hours.
The real value of the 24 hours end points is matter of
discussion since one can argue that an expression driven
by the T7 promoter is likely to cause a certain level of
metabolic breakdown of the cellular system and make
questionable a cultivation experiment for more than 25
hours post induction. Even if protein and/or induction
condition dependent, this is perfectly true but neverthe-
less important to document plasmid stability at end and
after normal end of fermentation to document regula-
tory files.
We have demonstrated, or at least re-demonstrated
that an appropriate stabilisation of the expression vector
Table 1 Example of Helicobacter pylori AlpA protein
produced in erlen flask in absence of Kanamycin
Culture
time
Plasmid
without cer
With cer
orientation1
With cer
orientation2
2 h(IPTG
added)
97% 100% 100%
4 h 25% 100% 100%
6 h 20% 75% 100%
23 h 3% 79% 97%
The contribution of the cer fragment in increasing the plasmid maintenance
over time is clearly established, a slight difference is observed according to
the relative orientation of cer but should be confirmed by additional
experiments.
Table 2 Example of Helicobacter pylori Urease produced
in erlen flask in absence of kanamycin
Culture
time
Plasmid without
cer
With cer
orientation1
With cer
orientation2
1 h 87% 100% 100%
2 h IPTG addition
3 h 67% 100% 100%
5 h 1% 50% 34%
25 h 0% 9% 8%
The contribution of the cer fragment in increasing the plasmid maintenance
over time is again clearly established with a different antigen, the difference
observed according to the relative orientation of cer is in the opposite
direction as compared to AlpA and likely to be non-significative.
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tion during culture.
Second step: evaluation of the poison/antidote system in
fermentation conditions
The original poison/antidote system was chosen for dif-
ferent reasons:
- the host/vector couple is commercially available
from Delphigenetics,
- the engineered strain is a BL21l(DE3) derivative,
making comparison with our standard process easier.
In a pharmaceutical context, the presence of minute
amount of ccdB as contaminant would be acceptable,
since no equivalent of gyrase is present in human cells.
The experiment was designed in order to show whether
this antibiotic-free selection would be applicable in fer-
mentation at 1 liter and larger scale.
The model system was based on the pM1816 vector
used for the production of recombinant Pseudomonas
exotoxin (rEPA), a pM1800 derivative vector containing
the kanamicyn resistance gene and the cer fragment.
The ccdA encoding gene extracted from the pStaby
cloning vector obtained from Delphigenetics was cloned
into the pM1816 expression vector generating the pSP1
construct. In order to eliminate the Kanamycin resis-
tance gene a digestion with ClaI and AscI restriction
enzymes followed by self-religation has been done.
Fermentation at 1 liter scale (table 3) was done in
absence of Kanamycin for pM1816 and 2 different
induction protocols were applied:
- a standard induction at high cell density (A600 = 25),
- an early induction (A600 = 1), not representative of
normal fermentation conditions, to increase the number
of cell divisions between induction and end of fermenta-
tion and thus artificially creating extended high stress
conditions. In that case the higher stress would be due
to high metabolic charge to ensure multiple cell divi-
sions in parallel to protein production. It is likely to say
that in such condition the probability to lose plasmid
would be greater than using induction at high cell den-
sity. The 3 following parameters have been monitored at
the end of fermentation:
- absorbance,
- percentage of cells still containing a plasmid,
- amount of recombinant protein expressed.
When standard fermentation conditions (A600 = 25)
are applied, the plasmid maintenance is at least equiva-
lent or superior when the poison antidote selection is
compared to the standard vector (98% versus 90%). The
unanticipated result is that the amount of expressed
antigen is two fold increased with the poison antidote
system (603 mg/L versus 280 mg/L) (Figure 1). This is
possibly due to a more complete elimination of bacteria
devoid of plasmid and thus preferable maintaining of
the hosts producing the recombinant protein of interest.
In the context of the experiment described, the antibio-
tic-resistance gene was eliminated through cut and re-
ligation leading to another possible and complementary
explanation. One can argue that the kanamycin resis-
tance gene, if present, even in absence of antibiotic pres-
sure, would be transcribed and translated and be
responsible for an additional stress on the cell machin-
ery and detrimental to the global expression of recombi-
nant antigen. We can assume that the transcription and
translation of ccdA, which is a small molecule, would
have a minor overloading effect on the cell machinery.
Table 3 Evaluation of antibiotic-free system in fermenters
(production of rEPA protein)
Induction at early stage
of growth
Induction at advanced
stage of growth
System
based on
kana
resistance
Antibiotic
free
system
System
based on
kana
resistance
Antibiotic
free
system
Cell dry weigh
(g/L)
28 23 22 24
Plasmid
retention (%)
5 100 90 98
Product yield
(mg/L)
36 350 280 603
Specific
productivity
(mg product/
gCDW)
11 5 1 3 2 5
Two conditions have been analyzed: induction at A600 = 25 (advanced stage
of growth), close to standard production, and induction at A600 = 1 (early
stage of growth) to increase the number of cell division between induction
and end of fermentation and introduce an extended high level of stress over
the cells.
In normal conditions the plasmid maintenance is increased and
productivity doubles. For extended stress condition, the differences between
antibiotic-free and standard are dramatic, both in terms of plasmid
maintenance and protein productivity.
Figure 1 protein production evaluation in 1 liter fermenter.
Upon induction, the behaviour of both systems is comparable but a
clear increase in protein production is observed with the antibiotic-
free system at the end of fermentation.
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1, Table 3 and Figure 2), the plasmid loss is extremely
rapid with the standard vector as compared to poison/
antidote (5% versus 100%), indicating the very stringent
selection of the ccdA/ccdB system. The 10 fold differ-
ence in the amount of expressed antigen is fully consis-
tent with the observed difference in term of plasmid
maintenance (36 mg/L versus 350 mg/L).
In order to evaluate the potential for scale-up, the fer-
mentation process previously established, for the stan-
dard conditions, was transposed at a 30 liters scale. As
indicated in table 4, values obtained for both optical
densities at different times and plasmid maintenance is
almost similar.
Third step: possible contribution of the cer locus
In order to evaluate the real contribution of the cer
locus on the observed increased expression level, a new
series of vectors capable to express the recombinant
AlpA protein have been assembled and tested: pM-
Hp3.1 (cer -, KanR +, ccdA-), pSP3 (cer-, KanR-, ccdA
+) and pSP5 (cer +, KanR-, ccdA+) (table 5).
A head to head comparison of protein of interest ver-
sus total proteins on a SDS-PAGE using densitometry
quantification (GeneTools software) clearly shows that
for a given antigen (figure 3):
- antibiotic-free selection - cer locus gives superior
production level (16,5%) compared to standard antibio-
tic selection - cer (14,5%).
- antibiotic-free selection + cer gives also superior pro-
duction (17,9%) compared to the same construct devoid
of cer locus (16,5%).
The following hierarchy can be established:
antibio-free + cer > antibio-free - cer > standard - cer
Even if limited to a single antigen, the experiment
shows a benefit, in terms of protein yield, by combining
the antibiotic-free selection and the stabilizing element.
Final step: elimination of the antibiotic resistance gene
Antibiotic selection and therefore, the presence of an
antibiotic resistance gene on the vector until the last
step of the expression are required to ensure the
absence of external contaminant cells that would not be
counter-selected by the poison/antidote system.
Even if antibiotic selection pressure is not used during
the fermentation process, removal of this antibiotic
resistance marker is of major importance to prevent
horizontal transfer in the environment. This is particu-
l a r l yt r u ef o rv e c t o r st ob eu s e di ng e n et h e r a p yo r
DNA vaccination protocols. For above mentioned rea-
sons (see second step) it is also important to eliminate
this sequence to improve both vector stability and
recombinant protein expression level.
Elimination of the antibiotic resistance marker can
be very simply obtained by restriction enzyme diges-
tion using unique sites flanking the sequence to be
removed followed by self-ligation of the vector. The
only issue being that the discrimination between cor-
rectly deleted and parental vectors is not directly pos-
sible and would involve time consuming analytical
techniques such as, restriction mapping following a
small scale DNA preparation or alternatively a PCR-
based approach.
In order to overcome the problem we have designed
a model, including a positive selection, in which the
antibiotic-free selection marker would be functional
only after proper elimination of the antibiotic resis-
tance gene. In this model (figures 4 and 5) the ccdA
locus is split into 2 parts, containing a common
sequence, and cloned in the 5’ and 3’ regions flanking
the antibiotic resistance gene. After digestion at a
unique restriction site located inside the antibiotic
selection marker and transformation of ccdB expres-
sing cells with linear DNA, a fully functional ccdA
would assemble through homologous recombination.
Only CYS21 and SE1 bacteria containing a recombi-
nant plasmid with a functional ccdA can grow upon
transformation.
Figure 2 Follow-up of Plasmid stability and Optical density for
cultures in fermenter (1 litre scale) upon induction at early
stage of growth. As early as 2 hours after induction the % of P+
cells start decreasing and drops dramatically after 4 hours for the
standard system. Virtually no decreasing effect is observed with the
antibiotic-free selection in the same conditions.
Table 4 Scale-up of antibiotic-free system
Fermenter scale 1 L 30 L
Induction time 3 h 20 h 3 h 20 h
A600 72 47 73 55
P+ % 100 98 100 100
rEPA (mg/L) 337 603 194 275
No marked differences appear between 1 liter and 30 liters fermentation for
the antibiotic-free system in terms of both, cell density and % of P+ cells.
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preparation
The above-described work is deliberately focused on
recombinant protein production, for which the advan-
tage of combining a stabilisation element and an anti-
biotic-free selection mean has been illustrated. It would
be easy to extrapolate and say that a system allowing
100% maintenance of plasmid during fermentation
would also give superior results in terms of amount of
p l a s m i dr e c o v e r y .W eh a v ed o n es o m ep r e l i m i n a r y
experiments towards that direction (data not shown).
The results observed are a tendency to obtain 10 to 20%
more plasmid with the antibio-free + cer plasmid. But,
only a repetition of large series of experiments would
allow us to be really confident on that observation, for
the following reasons:
- The techniques for midi or maxi plasmid DNA
extraction suffer from a certain batch to batch variability
(at least at lab scale),
- A real head to head comparison is difficult, since the
comparison has to be done with non-identical bacterial
strains (CYS21 vs DH10B in our case).
Nevertheless, we would say that, in addition to a
potential superiority in production, the real added value
of our system to plasmid DNA preparation is the one-
step selective elimination of the antibiotic resistance
gene that is mandatory for therapeutic applications.
Conclusions
Antibiotic-free selection is a general and ultimate goal
that can be attained by the implementation of various
and combined approaches. An increasing knowledge of
bacterial physiology will give access to more and more
essential genes or pathways that would be an unlimited
source of inspiration for the design of novel selection
means. The major driver for the definition of antibiotic-
free systems is a desire to anticipate and fulfil future
recommendations from health authorities to overcome
safety concerns but, interestingly it can give access to
unexpected properties such as a marked increase in
recombinant protein production or plasmid recovery.
The complete elimination of any antibiotic resistance
gene is, for different reasons, of critical importance for
both recombinant protein production and DNA immu-
nisation vectors. The proposed homologous recombina-
tion process has been demonstrated to be fully
functional and might be associated to different antibio-
tic-free expression systems or transferred to other
microorganisms.
Figure 3 Head to head comparison of the expression of the
same antigen with 3 different vectors. Helicobacter pylori AlpA
protein was produced in erlen flask in absence of Kanamycin using
three differents vectors: pM.H.P3.1 (control vector -cer), pSP3
(antibiotic-free vector -cer) and pSP5 (antibiotic-free vector +cer).
Total lysates of induced and non induced bacteria were loaded on
SDS-PAGE and a densitometry quantification of the recombinant
protein was performed using GeneTools software. This
quantification is expressed as a percentage of the protein of interest
compared to total proteins. The results show the contribution of
both antibiotic-free system and cer locus in protein expression
improvement (antibio-free + cer > antibio-free - cer > standard -
cer).
Table 5 Summary of plasmids used
Plasmid name Derived from plasmid Recombinant protein expressed F1 origin cer fragment Kanamycin resistance gene ccdA gene
pET28c -+ -+ -
pM1800 pET28c - - + + -
pMH.P3.1 pET28c AlpA + - + -
pM1816 pM1800 rEPA - + + -
pSP301 pM1800 - - + Rcb +
pSP1 pM1816 rEPA - + - +
pSP2 pSP301 - - - Rcb +
pSP3 pSP2 AlpA - - Rcb +
pSP4 pSP2 rEPA - - Rcb +
pSP5 pSP301 AlpA - + Rcb +
pSP6 pSP301 rEPA - + Rcb +
-: absent; +: present; Rcb: kanamycin resistance gene is deleted through homologous recombination.
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Vector containing the cer fragment: pM1800 and its
derivatives
Table 5 summarizes the properties of mentioned
plasmids.
The pET28c vector (Novagen) was amplified by PCR
using the « expand long template PCR system » kit
from Boehringer Mannheim in order to suppress the f1
origin.
The 5’ primer carried the site AscI and the 3’ primer,
AscI and PacI. After amplification, the PCR product was
purified, AscI (New England Biolabs) digested and self-
ligated with T4 DNA ligase, (New England Biolabs).
A 300 bp fragment containing the sequence of cer
fragment was obtained by PCR amplification using the
pXL 2979 plasmid (gift of Rhône Poulenc) as matrix.
After purification, the PCR product was digested by
AscI and PacI (New England Biolabs), and was cloned
into pET28c devoid of f1 origin previously obtained
digested by these same enzymes. This new plasmid was
termed pM1800.
The same strategy has been used to obtain the same
plasmid with a cer fragment in the opposite orientation.
To express AlpA protein, the H. pylori X47-2 strain
was used as a source of DNA. A 1.6 kb DNA fragment
containing the sequence encoding the mature AlpA pro-
tein was amplified by PCR and cloned into pM1800
between the NcoI and XhoI restriction sites, yielding the
pM-Hp3.1. (figure 6).
To express the recombinant exoprotein A from
Pseudomonas aeruginosa (rEPA), the plasmid pVC45 D
(an Ampicillin resistant plasmid provided by Temple
University, USA) containing the recombinant exoprotein
A (rEPA)g e n ec l o n e di nf u s i o nw i t ht h eOmpA signal
sequence between HindIII and EcoRI sites has been
used. To avoid a PCR step, this plasmid was digested by
XbaI (New England Biolabs) and EcoRI (New England
Biolabs) to isolate the fragment containing the RBS
sequence and the OmpA-rEPA fusion (2024 bp). After
purification, the fragment was cloned into plasmid
pM1800 digested by the same enzymes to create plas-
mid pM1816 (7195 bp).
Vector containing the ccdA fragment: pSP301, pSP1, pSP2
and their derivatives
First the pM1800 has been amplified by a PCR reaction
to eliminate the kanamycin resistance gene and to create
the PstI and Acc65I sites. In the same way the fragment
containing the mob promoter, the 5’ part of ccdA,t h e
kanamycin resistance gene and the 3’ part of ccdA gene
(figure 5) was constructed by combining and extending
PCR amplicons. Both, the 5’ ccdA and 3’ ccdA fragments
contain the same 120 bp sequence. Finally, the PCR pro-
duct was digested by PstI (New England Biolabs) and
Acc65I (New England Biolabs) and cloned in the
pM1800 devoid kanamycin resistance gene. The new
plasmid was termed pSP301 (figure 7).
Then, pSP301 vector was digested by PacI (New Eng-
land Biolabs) and AscI (New England Biolabs) to
Figure 4 Homologous recombination process allowing
assembly of a functional ccdA encoding gene. After
transformation of SE1 bacteria expressing the ccdB gene product
with linearized plasmid DNA, a functional ccdA gene is assembled
through homologous recombination. The expression of the ccdA
gene product allows survival of the recipient strain and provides a
positive selection ensuring the elimination of the Kanamycine
resitance gene.
Figure 5 Construction by combined PCR of the 5’ccdA-
Kanamycin-3’ccdA fragment. In green the 120 bp sequence
identical in 5’ccdA and 3’ ccdA fragment and target sites for
homologous recombination, in blue the kanamycin resistance gene.
Homologous recombination ensures the complete elimination of
the Kanamycin resistance gene.
Figure 6 Plasmid pM-Hp 3.1, derivative of pET28, original
construct expressing the Helicobacter pylori AlpA antigen.
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digested by the Mung Bean exonuclease (New England
Biolabs), and the plasmid was self- ligated to create the
new vector pSP2.
The pM1816 plasmid has been also modified to
express the rEPA protein and ccdA.T h emob promoter
and the ccdA gene were amplified from the pStaby (Del-
phigentics) and cloned into pM1816 between the site
Not I and EcoR I. To eliminate the Kanamycin resis-
tance gene, this new plasmid pM1816+ccdA was
digested by ClaI (New England Biolabs) and AscI (New
England Biolabs). The cohesive ends were digested by
the Mung Bean exonuclease (New England Biolabs), and
the plasmid was self-ligated to create the new vector
pSP1 (figure 8).
The XbaI-EcoRI fragment containing the RBS
sequence and the OmpA-rEPA fusion, isolated from this
pM1816 vector was cloned into both pSP2 and pSP301
between the same unique restriction sites. The kanamy-
cin resistance gene of these new plasmids (pSP2+ rEPA;
pSP301+rEPA) was eliminated by recombination yield-
ing pSP4 and pSP6 respectively (figures 9 and 10).
For AlpA the same strategy has been used. The XbaI-
XhoI fragment containing the sequence of the mature
AlpA isolated from the pM-Hp3.1 vector, was cloned
into both pSP2 and pSP301 between the same unique
restriction sites. The kanamycin resistance gene of these
new plasmids (pSP2+ AlpA; pSP301+AlpA) was elimi-
nated by recombination yielding pSP3 and pSP5 respec-
tively (figure 11).
Figure 7 Plasmid pSP301 containing a Kanamycin resistance
gene flanked by 5’ and 3’ parts of the ccdA gene (non
functional).
Figure 8 Plasmid pSP1 containing the functional ccdA cassette,
the cer fragment and an almost completely truncated
kanamycin resistance gene.
Figure 9 Plasmid pSP4, similar to pSP1 but devoid of cer
fragment.
Figure 10 Plasmid pSP6, similar to pSP1 but completely
devoid of Kanamycin resistance gene.
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functional ccdA
To use the ccdA/ccdB selection system, the Kanamycin
resistance gene was eliminated through homologous
recombination. The pSP301 and derived plasmids were
digested by ClaI (New England Biolabs). The CYS21
strain (DH10B derived with ccdB in the chromosome)
(Delphigenetics) was transformed with the linear plas-
mid, and plated on LB agar. Only the clones containing
a correctly recombined plasmid encoding a functional
ccdA gene could grow. The presence of ccdA was
checked by enzymatic digestion and sequencing.
Cla I is a unique site in the kanamycin resistance gene,
and EcoR V is unique in the vector. When the vector
contains the Kanamycin resistance gene two bands are
present for the ClaI-EcoRV digestion. If the recombina-
tion event behaves as expected and eliminates the kana-
mycin resistance gene, only one band is likely to be
present for the ClaI-EcoRV digestion (data not shown).
Expression at lab scale
To express the recombinant proteins the SE1 bacteria
d e r i v e df r o mB L 2 1 l(DE3) (with ccdB in the chromo-
some) were transformed with pSP1, pSP3, pSP4, pSP5
and pSP6, and plated on LB agar. Similarly, the BL21l
(DE3) strain (Invitrogen) was transformed with the
PM1816 or pM-Hp3.1 and plated on LB kanamycin (25
μg/ml). An overnight culture for each construction was
diluted 1/100 in 50 ml of fresh LB with or without Kana-
mycin. All cultures were grown at 37°C to an A600 =0 . 4 -
0.6. The cultures were divided in 2 × 25 ml and the
expression of the recombinant exoprotein A was induced
using 1 mM Isopropyl-b-D-thiogalactopyranoside (IPTG)
in one of 25 ml culture. The induced and non-induced
bacteria were grown at 37°C up to 25 H post induction.
Evaluation in fermenters
The comparison at bench scale of the new system with the
existing system based on the kanamycin resistance involves
studies of plasmid retention, product yield and robustness.
The cultures at lab scale were conducted with the Bio-
stat Q BBi Sartorius system which includes 4 individual
fermentors of 500 ml as working volume.
The culture at pilot scale was conducted in a Appli-
kon fermentor of 30 liters as working volume. This is
the current scale for clinical batches for a phase 1 study.
The medium used is a “in house” propietary complex
medium (Yeast extract as source of nitrogen and dex-
trose as source of carbon) without the use of antibiotics.
Cultures were regularly sampled to monitor the in-
process parameters such as A600,C e l lD r yW e i g h t
(CDW) (g/L), numeration (CFU/ml), product yield and
plasmid retention (%).
Product yield
Each sample of cultures was treated by osmotic shock to
release the periplasmic content. Following this, each
extract was titrated by ELISA and loaded on SDS-
PAGE. A densitometry quantification has been done
using GeneTools software to compare the protein of
interest versus total proteins.
Plasmid stability monitoring
Samples of cultures were diluted and then, plated on
solid media for the numeration.
For the system based on the kanamycin resistance, 100
individual colonies were picked on LB agar supplemen-
ted with kanamycin (25 μg/mL).
For the antibiotic free system, 96 colonies were picked
to inoculate individual liquid cultures in microplates.
After 24 h of incubation, the plate was centrifuged and
then placed into a robotic pDNA extraction system
(QIAgen bioroBot® System). Finally, the samples were
loaded on 1% agarose gel to detect the presence or
absence of plasmid.
T h er e a d o u to ft h es t a b i l i t yi sp r o v i d e db yas i m p l e
numeration of colonies still containing the plasmid as a
percentage of the total analyzed colonies.
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